a year ago
GEHC
AnalystsDavid RomanDavid Roman's Stock Forecasts
AnalystsDavid Roman
Analyst Ranking
Bottom 8%
#4886 out of 5301 analysts
Average Return
-4.11%
Win Rate
42%20 out of 48
Risk vs Reward
Poor
Good
David Roman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Livanova PLCLIVN | +68.43% | $41.72 | $70.27 | 2025-03-03 - 2026-03-02 | Strong Buy |
Doximity IncDOCS | +61.07% | $70.64 | $27.50 | 2025-10-01 - 2026-02-09 | Strong Sell |
Glaukos CorpGKOS | +57.09% | $83.19 | $130.68 | 2025-10-01 - 2026-06-18 | Strong Buy |
Omada Health IncOMDA | +47.25% | $11.98 | $17.64 | 2026-04-09 - 2026-06-18 | Strong Buy |
Beta Bionics IncBBNX | +44.13% | $9.63 | $13.88 | 2026-04-09 - 2026-06-18 | Strong Buy |
David Roman Analyst Color
Get additional color on David Roman's coverage of popular stocks
David Roman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Medtronic PLCMDT | 3 | Hold | $83.00 | +4.61% | Maintains | 15 days ago |
Mobia Medical IncMOBI | 1 | Strong Buy | $31.00 | +117.54% | Initiates Coverage On | 18 days ago |
Beta Bionics IncBBNX | 5 | Strong Buy | $17.00 | +22.48% | Maintains | 24 days ago |
Doximity IncDOCS | 8 | Hold | $24.00 | +17.30% | Maintains | a month ago |
Ge Healthcare Technologies IncGEHC | 5 | Hold | $65.00 | +5.54% | Downgrades | 2 months ago |
Boston Scientific CorpBSX | 3 | Strong Buy | $84.00 | +85.47% | Maintains | 2 months ago |
Becton Dickinson & CoBDX | 2 | Hold | $167.00 | +15.99% | Reinstates | 2 months ago |
Tandem Diabetes Care IncTNDM | 3 | Hold | $25.00 | +63.40% | Maintains | 2 months ago |
Stryker CorpSYK | 3 | Hold | $357.00 | +15.98% | Maintains | 2 months ago |
Omada Health IncOMDA | 2 | Strong Buy | $23.00 | +30.39% | Maintains | 2 months ago |
Kestra Medical Technologies LtdKMTS | 4 | Hold | $17.00 | -14.70% | Maintains | 2 months ago |
Irhythm Holdings IncIRTC | 5 | Hold | $147.00 | +40.47% | Maintains | 2 months ago |
Intuitive Surgical IncISRG | 2 | Strong Buy | $609.00 | +49.71% | Maintains | 2 months ago |
Insulet CorpPODD | 3 | Strong Buy | $277.00 | +90.04% | Maintains | 2 months ago |
Carlsmed IncCARL | 2 | Strong Buy | $17.00 | +68.82% | Maintains | 2 months ago |
Abbott LaboratoriesABT | 3 | Strong Buy | $121.00 | +36.86% | Maintains | 2 months ago |
Baxter International IncBAX | 5 | Hold | $17.00 | -14.53% | Maintains | 4 months ago |
Edwards Lifesciences CorpEW | 5 | Strong Buy | $95.00 | +8.75% | Maintains | 4 months ago |
Medline IncMDLN | 1 | Strong Buy | $49.00 | +36.34% | Initiates Coverage On | 5 months ago |
Healthequity IncHQY | 4 | Strong Sell | $89.00 | +4.45% | Downgrades | 5 months ago |
Cooper Companies IncCOO | 2 | Strong Sell | $71.00 | +7.72% | Maintains | 6 months ago |
Bausch & Lomb CorpBLCO | 1 | Hold | $16.00 | +7.60% | Initiates Coverage On | 9 months ago |
Glaukos CorpGKOS | 1 | Strong Buy | $103.00 | -21.18% | Initiates Coverage On | 9 months ago |
Shoulder Innovations IncSI | 1 | Strong Buy | $20.00 | +7.82% | Initiates Coverage On | 10 months ago |
Zimmer Biomet Holdings IncZBH | 2 | Hold | $104.00 | N/A | Maintains | a year ago |
Teladoc Health IncTDOC | 4 | Strong Buy | $10.00 | N/A | Maintains | a year ago |
Solventum CorpSOLV | 4 | Strong Sell | $71.00 | N/A | Maintains | a year ago |
Livanova PLCLIVN | 2 | Strong Buy | $55.00 | N/A | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.